Pfizer Declares First-Quarter 2013 Dividend

Pfizer Declares First-Quarter 2013 Dividend

<0> Pfizer Inc.MediaJoan Campion, 212-733-2798orInvestorsSuzanne Harnett, 212-733-8009 </0>

The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 24-cent first-quarter 2013 dividend on the company’s common stock, payable March 5, 2013, to shareholders of record at the close of business on February 1, 2013. Pfizer increased the dividend by approximately 9 percent, to 24 cents from 22 cents per share.

The first-quarter 2013 cash dividend will be the 297 consecutive quarterly dividend paid by Pfizer.

“The dividend increase is a testament to our continued commitment to returning capital to shareholders and demonstrates our continued confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer. “We remain focused on total return to shareholders, of which the dividend is a key component.”

Suggested Articles

Merck is scouting replacements for CEO Ken Frazier with a preference toward an internal candidate, Bloomberg reports.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Riival generics makers are squashing long-running lawsuits over their own versions of Sanofi's big-selling blood thinner Lovenox.